Resources from the same session
HER2 inhibition: Agnostic approach or disease-specific strategy?
Presenter: Filippo Pietrantonio
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Targeted options in patients with RAS or BRAF mutant tumours: Not only a colorectal cancer matter
Presenter: Dominik Modest
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Other emerging targeted agents in different GI cancers: Are they ready for primetime?
Presenter: Kohei Shitara
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Rare targets and comprehensive genome profiling
Presenter: Angela Lamarca
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast